Bicalutamide Tablet
Product Images NDC 71205-577

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bicalutamide (NDC 71205-577). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-577-30 (Bicalutamide 30 Label)

Bicalutamide 50 mg tablets label from Proficient Rx LP. The label indicates 30 tablets per package with each containing 50 mg of Bicalutamide USP. The tablets are described as white to off-white, round, biconvex, film-coated with 'B 50' debossed on one side. The manufacturer is Intas Pharmaceuticals Limited, India. The label includes NDC 71205-577-30 and standard storage instructions.*

FDA Label Image

Fig_1 (Bicalutamide Fig 1)

A survival curve chart showing proportion surviving over time in days to death. Two groups are compared: Bicalutamide plus LHRH-A (solid line) and Flutamide plus LHRH-A (dashed line), with survival decreasing over approximately 1825 days.*

FDA Label Image

Fig_2 (Bicalutamide Fig 2)

A Kaplan-Meier survival curve graph comparing the proportion of patients not progressing over time (days to progression) for two treatments: Bicalutamide plus LHRH-A and Flutamide plus LHRH-A. The y-axis shows the proportion not progressing, and the x-axis shows days to progression up to 1825 days.*

FDA Label Image

Chem (Bicalutamide Str)

Chemical structure of bicalutamide, showing its molecular formula as C18H14N2O4F4S with detailed atomic connectivity including a trifluoromethyl group, cyano group, and sulfonyl group attached to aromatic rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.